Camp4 Therapeutics | SC 13G:超过5%持股股东披露文件-Michael P. Rubin(11.5%),Northpond Ventures II, LP(5.1%)等
Camp4 Therapeutics | SC 13D:超过5%持股股东披露文件-Amir Nashat(13.5%),Polaris Management Co. VII, L.L.C.(8.8%)等
Camp4 Therapeutics | 4/A:持股变动声明(修正)-股东 Polaris Management Co. VII, L.L.C.
Camp4 Therapeutics | 3/A:首次持股声明(修正)-股东 Polaris Partners GP X, L.L.C.
Camp4 Therapeutics | SC 13G:超过5%持股股东披露文件-Marc Andreessen(10.9%),Benjamin Horowitz(10.9%)等
Camp4 Therapeutics | SC 13D:超过5%持股股东披露文件-Enavate Sciences GP, LLC(19.4%),Everest Aggregator, LP(19.4%)
Camp4 Therapeutics | SC 13D:超过5%持股股东披露文件-Andrew J. Schwab(15.0%),Dr. Kush Parmar(15.0%)等
Camp4 Therapeutics | 4:持股变动声明-股东 Northpond Ventures II GP, LLC
Camp4 Therapeutics | 4:持股变动声明-股东 AH Equity Partners Bio I, L.L.C.
Camp4 Therapeutics | 4:持股变动声明-股东 Enavate Sciences GP, LLC
Camp4 Therapeutics | 4:持股变动声明-股东 Polaris Management Co. VII, L.L.C.
Camp4 Therapeutics | 4:持股变动声明-股东 5AM Partners VI, LLC
Camp4 Therapeutics | 4:持股变动声明-董事 Schwab Andrew J.
Camp4 Therapeutics | 4:持股变动声明-董事 Nashat Amir
Camp4 Therapeutics | 4:持股变动声明-董事 Holtzman Steven H
Camp4 Therapeutics | 4:持股变动声明-董事 Young Richard A
Camp4 Therapeutics | 4:持股变动声明-高管 Mandel-Brehm Josh
Camp4 Therapeutics | 3:首次持股声明-股东 Polaris Partners GP X, L.L.C.
Camp4 Therapeutics Corp. | 3:首次持股声明-股东 Polaris Management Co. VII, L.L.C.
Camp4 Therapeutics Corp. | 3:首次持股声明-股东 Enavate Sciences GP, LLC